FITC Anti-Mouse CD45.2 (104)
The 104 antibody reacts with mouse CD45.2, also known as Ly5.2, which is a strain-specific allelic form of the CD45 Leukocyte Common Antigen (LCA). Functionally, CD45 is a protein tyrosine phosphatase whose broad cell distribution supports a critical role in many leukocyte functions, including regulation of signal transduction and cell activation associated with the T cell and B cell receptors.
The 104 antibody is typically used as a leukocyte marker in Ly5.2 mouse strains C57BL/6, BALB/c, C58, DBA/1, DBA/2, C3H/He, CBA, 129, A and AKR. The antibody has been demonstrated to be specific for CD45.2 and is not cross-reactive with CD45.1-bearing cells.
Recent Citations:
Burbach BJ, O'Flanagan SD, Shao Q, et al. Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells. Nat Commun. 2021 Jun 23;12(1):3862. doi: 10.1038/s41467-021-24132-6. PMID: 34162858.
| Name | FITC Anti-Mouse CD45.2 (104) |
|---|---|
| Cat. No. | 35-0454 |
| Alternative Names | Ly5.2 |
| Gene ID | 19264 |
| Clone | 104 |
| Isotype | Mouse IgG2a, κ |
| Reactivity | Mouse |
| Format | FITC |
| Application | Flow Cytometry |
Original: $33.00
-70%$33.00
$9.90More Images
FITC Anti-Mouse CD45.2 (104)
The 104 antibody reacts with mouse CD45.2, also known as Ly5.2, which is a strain-specific allelic form of the CD45 Leukocyte Common Antigen (LCA). Functionally, CD45 is a protein tyrosine phosphatase whose broad cell distribution supports a critical role in many leukocyte functions, including regulation of signal transduction and cell activation associated with the T cell and B cell receptors.
The 104 antibody is typically used as a leukocyte marker in Ly5.2 mouse strains C57BL/6, BALB/c, C58, DBA/1, DBA/2, C3H/He, CBA, 129, A and AKR. The antibody has been demonstrated to be specific for CD45.2 and is not cross-reactive with CD45.1-bearing cells.
Recent Citations:
Burbach BJ, O'Flanagan SD, Shao Q, et al. Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells. Nat Commun. 2021 Jun 23;12(1):3862. doi: 10.1038/s41467-021-24132-6. PMID: 34162858.
| Name | FITC Anti-Mouse CD45.2 (104) |
|---|---|
| Cat. No. | 35-0454 |
| Alternative Names | Ly5.2 |
| Gene ID | 19264 |
| Clone | 104 |
| Isotype | Mouse IgG2a, κ |
| Reactivity | Mouse |
| Format | FITC |
| Application | Flow Cytometry |
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
The 104 antibody reacts with mouse CD45.2, also known as Ly5.2, which is a strain-specific allelic form of the CD45 Leukocyte Common Antigen (LCA). Functionally, CD45 is a protein tyrosine phosphatase whose broad cell distribution supports a critical role in many leukocyte functions, including regulation of signal transduction and cell activation associated with the T cell and B cell receptors.
The 104 antibody is typically used as a leukocyte marker in Ly5.2 mouse strains C57BL/6, BALB/c, C58, DBA/1, DBA/2, C3H/He, CBA, 129, A and AKR. The antibody has been demonstrated to be specific for CD45.2 and is not cross-reactive with CD45.1-bearing cells.
Recent Citations:
Burbach BJ, O'Flanagan SD, Shao Q, et al. Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells. Nat Commun. 2021 Jun 23;12(1):3862. doi: 10.1038/s41467-021-24132-6. PMID: 34162858.
| Name | FITC Anti-Mouse CD45.2 (104) |
|---|---|
| Cat. No. | 35-0454 |
| Alternative Names | Ly5.2 |
| Gene ID | 19264 |
| Clone | 104 |
| Isotype | Mouse IgG2a, κ |
| Reactivity | Mouse |
| Format | FITC |
| Application | Flow Cytometry |
